Human Genome Epidemiology Literature Finder
Rare Diseases
Records 1 - 30 (of 40 Records) |
Query Trace: Anaplastic Astrocytoma[original query] |
---|
MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation. Journal of neuro-oncology 2011 Feb 101 (3): 405-17. Groenendijk Floris H, Taal Walter, Dubbink Hendrikus J, Haarloo Cathleen R, Kouwenhoven Mathilde C, van den Bent Martin J, Kros Johan M, Dinjens Winand N |
Glutathione S-transferase polymorphisms are associated with survival in anaplastic glioma patients. Cancer 2010 May 116 (9): 2242-9. Kilburn Lindsay, Okcu M Fatih, Wang Tao, Cao Yumei, Renfro-Spelman Amy, Aldape Kenneth D, Gilbert Mark R, Bondy Melis |
IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance. American journal of clinical pathology 2012 Aug 138 (2): 177-84. Thota Balaram, Shukla Sudhanshu K, Srividya Mallavarapu R, Shwetha Shivayogi D, Arivazhagan Arimappamagan, Thennarasu Kandavel, Chickabasaviah Yasha T, Hegde Alangar S, Chandramouli Bangalore A, Somasundaram Kumarvel, Santosh Va |
DMBT1 homozygous deletion in diffuse astrocytomas is associated with unfavorable clinical outcome. Journal of neuropathology and experimental neurology 2012 Aug 71 (8): 702-7. Motomura Kazuya, Mittelbronn Michel, Paulus Werner, Brokinkel Benjamin, Keyvani Kathy, Sure Ulrich, Wrede Karsten, Nakazato Yoichi, Tanaka Yuko, Pierscianek Daniela, Kim Young-Ho, Mariani Luigi, Vital Anne, Ohgaki Hiro |
1p/19q codeletion and IDH1/2 mutation identified a subtype of anaplastic oligoastrocytomas with prognosis as favorable as anaplastic oligodendrogliomas. Neuro-oncology 2013 Mar . Jiang H, Ren X, Cui X, Wang J, Jia W, Zhou Z, Lin S |
Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China. Journal of cancer research and clinical oncology 2014 Jan 140 (1): 45-51. Zhang Chuan-Bao, Bao Zhao-Shi, Wang Hong-Jun, Yan Wei, Liu Yan-Wei, Li Ming-Yang, Zhang Wei, Chen Ling, Jiang T |
The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma. Journal of neuro-oncology 2014 Oct 120 (1): 85-93. Kizilbash Sani H, Giannini Caterina, Voss Jesse S, Decker Paul A, Jenkins Robert B, Hardie John, Laack Nadia N, Parney Ian F, Uhm Joon H, Buckner Jan |
IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy. Journal of neuro-oncology 2014 Jun 118 (2): 377-83. Minniti Giuseppe, Scaringi Claudia, Arcella Antonella, Lanzetta Gaetano, Di Stefano Domenica, Scarpino Stefania, Bozzao Alessandro, Pace Andrea, Villani Veronica, Salvati Maurizio, Esposito Vincenzo, Giangaspero Felice, Enrici Riccardo Mauri |
Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas. Neuropathology : official journal of the Japanese Society of Neuropathology 2015 Aug 35 (4): 324-35. Ogura Ryosuke, Tsukamoto Yoshihiro, Natsumeda Manabu, Isogawa Mizuho, Aoki Hiroshi, Kobayashi Tsutomu, Yoshida Seiichi, Okamoto Kouichiro, Takahashi Hitoshi, Fujii Yukihiko, Kakita Akiyos |
Prognostic value of epidermal growth factor receptor amplification and EGFRvIII in glioblastoma: meta-analysis. Acta neurologica Scandinavica 2015 Apr . Chen J-R, Xu H-Z, Yao Y, Qin Z |
Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach. Journal of clinical pathology 2016 Jan . Rajmohan K S, Sugur Harsha S, Shwetha S D, Ramesh Arvind, Thennarasu Kandavel, Pandey Paritosh, Arivazhagan Arimappamagan, Santosh Va |
The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas. Acta neuropathologica communications 2017 Aug 5 (1): 62. Lee Yujin, Koh Jaemoon, Kim Seong-Ik, Won Jae Kyung, Park Chul-Kee, Choi Seung Hong, Park Sung-H |
[Prognostic significance of combined TERT and IDH gene mutation analysis in diffusely infiltrating gliomas]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2018 9 47 (9): 658-663. Liu Q Q, Yin X X, Zou Y, Yu T P, Gong J, Chen X Q, Nie L, Xu M, Zhang M N, Zhou Q, Chen |
Cerebellar glioblastoma: a clinical series with contemporary molecular analysis. Acta neurochirurgica 2018 9 160 (11): 2237-2248. Hong Bujung, Banan Rouzbeh, Christians Arne, Nakamura Makoto, Lalk Michael, Lehmann Ulrich, Hartmann Christian, Krauss Joachim |
IDH1, ATRX, and BRAFV600E mutation in astrocytic tumors and their significance in patient outcome in north Indian population. Surgical neurology international 2018 9 29. Chatterjee Debajyoti, Radotra Bishan Dass, Kumar Narendra, Vasishta Rakesh Kumar, Gupta Sunil Kum |
Clinical significance of the 2016 WHO classification in Japanese patients with gliomas. Brain tumor pathology 2018 2 35 (2): 71-80. Iuchi Toshihiko, Sugiyama Takahiro, Ohira Miki, Kageyama Hajime, Yokoi Sana, Sakaida Tsukasa, Hasegawa Yuzo, Setoguchi Taiki, Itami Maki |
The role of ABO blood groups in glial neoplasms. British journal of neurosurgery 2019 Feb 33 (1): 43-46. Alkan Ali, Yaz?c? Gözde, Cengiz Mustafa, Karaka? Yusuf, Çelik ?smail, Kars Ay?e, Zorlu Far |
Clinical relevance of molecular subgrouping of gliomatosis cerebri per 2016 WHO classification: a clinicopathological study of 89 cases. Brain pathology (Zurich, Switzerland) 2019 8 30 (2): 235-245. Kwon Mi Jung, Kang So Young, Cho Haeyon, Lee Jung Il, Kim Sung Tae, Suh Yeon-L |
Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II-III gliomas to establish genetic predictors of poor prognosis. Brain tumor pathology 2019 Jul . Kuwahara Kiyonori, Ohba Shigeo, Nakae Shunsuke, Hattori Natsuki, Pareira Eriel Sandika, Yamada Seiji, Sasaki Hikaru, Abe Masato, Hasegawa Mitsuhiro, Hirose Yuic |
ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data. Radiation oncology (London, England) 2020 Jul 15 (1): 184. Kim Nalee, Kim Se Hoon, Kang Seok-Gu, Moon Ju Hyung, Cho Jaeho, Suh Chang-Ok, In Yoon Hong, Chang Jong H |
Can quantifying the extent of 'high grade' features help explain prognostic variability in anaplastic astrocytoma? British journal of neurosurgery 2020 12 1-8. Goacher Edward, Mathew Ryan, Fayaye Oluwafikayo, Chakrabarty Aruna, Feltbower Richard, Loughrey Carmel, Roberts Paul, Chumas Pa |
Cerebellar anaplastic astrocytoma in adult patients: 15 consecutive cases from a single institution and literature review. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2021 8 91 249-254. Belyaev Artem, Usachev Dmitry, Ryzhova Marina, Gulida Gleb, Skvortsova Vasilisa, Pronin Igor, Kobiakov Grigo |
Molecular biomarkers and integrated pathological diagnosis in the reclassification of gliomas. Molecular and clinical oncology 2021 6 15 (2): 150. Ruiz María Fernanda, Gennaro María Verónica, Bastone Laura C, Godoy Alicia R, Torruella Mónica, Perez Germán |
Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Neuro-oncology 2021 4 23 (9): 1547-1559. Tesileanu C Mircea S, van den Bent Martin J, Sanson Marc, Wick Wolfgang, Brandes Alba A, Clement Paul M, Erridge Sara C, Vogelbaum Michael A, Nowak Anna K, Baurain Jean F, Mason Warren P, Wheeler Helen, Chinot Olivier L, Gill Sanjeev, Griffin Matthew, Rogers Leland, Taal Walter, Rudà Roberta, Weller Michael, McBain Catherine, van Linde Myra E, Sabedot Thais S, Hoogstrate Youri, von Deimling Andreas, de Heer Iris, van IJcken Wilfred F J, Brouwer Rutger W W, Aldape Kenneth, Jenkins Robert B, Dubbink Hendrikus J, Kros Johan M, Wesseling Pieter, Cheung Kin Jip, Golfinopoulos Vassilis, Baumert Brigitta G, Gorlia Thierry, Noushmehr Houtan, French Pim |
Genetic signature and treatment of pediatric high-grade glioma. Molecular and clinical oncology 2021 Apr 14 (4): 70. Guidi Milena, Giunti Laura, Buccoliero Anna Maria, Caporalini Chiara, Censullo Maria Luigia, Galli Luisa, Genitori Lorenzo, Sardi Iaco |
SNP-based detection of allelic imbalance: A novel approach for identifying KIAA1549-BRAF fusion in pilocytic astrocytoma using DNA sequencing. Experimental and molecular pathology 2021 2 120 104621. Bobach Ida Schwartz, Stougaard Magn |
Diffuse Gliomas of the Brainstem and Cerebellum in Adults Show Molecular Heterogeneity. The American journal of surgical pathology 2021 2 45 (8): 1082-1090. Eschbacher Kathryn L, Ida Cristiane M, Johnson Derek R, Alvi Mohammed A, Jenkins Sarah M, Ruff Michael W, Kerezoudis Panagiotis, Neth Bryan J, Pasion Romela M, Daniels David J, Kizilbash Sani H, Raghunathan Adit |
Pharmacogenetics of ATP binding cassette transporter MDR1(1236C>T) gene polymorphism with glioma patients receiving Temozolomide-based chemoradiation therapy in Indian population. The pharmacogenomics journal 2021 Feb . Munisamy Murali, Munisamy Srinivasan, Kumar Julka Pramod, Jose Anmi, Thomas Levin, Baburaj Gayathri, Subbiah Vivekanandh |
H3K27M-Altered Diffuse Midline Gliomas Among Adult Patients: A Systematic Review of Clinical Features and Survival Analysis. World neurosurgery 2022 6 165 e251-e264. Bin-Alamer Othman, Jimenez Adrian E, Azad Tej D, Bettegowda Chetan, Mukherjee Debr |
[Prognosis of overall and disease-free survival in patients with grade 3 astrocytomas (anaplastic astrocytoma, WHO 2016)]. Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko 2023 8 87 (4): 46-57. A Yu Belyaev, G L Kobyakov, P N Shmakov, K V Efremov, I N Pronin, D Yu Usach |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: